BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34251535)

  • 1. Salivary IL-8 as a putative predictive biomarker of radiotherapy response in head and neck cancer patients.
    Principe S; Zapater-Latorre E; Arribas L; Garcia-Miragall E; Bagan J
    Clin Oral Investig; 2022 Jan; 26(1):437-448. PubMed ID: 34251535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Cytokines in patients with Head and Neck Cancer (HNC) treated with Radiotherapy.
    Principe S; Dikova V; Bagán J
    J Clin Exp Dent; 2019 Nov; 11(11):e1072-e1077. PubMed ID: 31700580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there difference in the comparative and quantitative salivary proteome between stimulated and unstimulated saliva in head and neck cancer patients treated by radiotherapy?
    Ventura TMO; Santos PSS; Ribeiro NR; de Lima Leite A; Taira EA; Dionizio A; Rubira CMF; Buzalaf MAR
    Oral Oncol; 2021 Jul; 118():105315. PubMed ID: 33985911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
    Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies.
    Citrin DE; Hitchcock YJ; Chung EJ; Frandsen J; Urick ME; Shield W; Gaffney D
    Radiat Oncol; 2012 Apr; 7():64. PubMed ID: 22537315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy changes the salivary proteome in head and neck cancer patients: evaluation before, during, and after treatment.
    Ventura TMO; Ribeiro NR; Taira EA; de Lima Leite A; Dionizio A; Rubira CMF; da Silva Santos PS; Buzalaf MAR
    Clin Oral Investig; 2022 Jan; 26(1):225-258. PubMed ID: 34052889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients.
    Oton-Leite AF; Silva GB; Morais MO; Silva TA; Leles CR; Valadares MC; Pinezi JC; Batista AC; Mendonça EF
    Lasers Surg Med; 2015 Apr; 47(4):296-305. PubMed ID: 25824475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between the severity of radiation-induced oral mucositis and salivary epidermal growth factor as well as inflammatory cytokines in patients with head and neck cancer.
    Xu J; Yang G; An W; Wang W; Li F; Meng Y; Wang X
    Head Neck; 2023 May; 45(5):1122-1129. PubMed ID: 36866530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
    Aziz S; Ahmed SS; Ali A; Khan FA; Zulfiqar G; Iqbal J; Khan AA; Shoaib M
    Cancer Invest; 2015; 33(7):318-28. PubMed ID: 26046681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; Burlage FR; Koken PW; Doornaert P; Bijl HP; Chouvalova O; Leemans CR; de Bock GH; Christianen ME; van der Laan BF; Vissink A; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):86-93. PubMed ID: 21632133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
    Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin treatment suppresses IKKβ kinase activity of salivary cells of patients with head and neck cancer: a pilot study.
    Kim SG; Veena MS; Basak SK; Han E; Tajima T; Gjertson DW; Starr J; Eidelman O; Pollard HB; Srivastava M; Srivatsan ES; Wang MB
    Clin Cancer Res; 2011 Sep; 17(18):5953-61. PubMed ID: 21821700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC5B levels in submandibular gland saliva of patients treated with radiotherapy for head-and-neck cancer: a pilot study.
    Dijkema T; Terhaard CH; Roesink JM; Raaijmakers CP; van den Keijbus PA; Brand HS; Veerman EC
    Radiat Oncol; 2012 Jun; 7():91. PubMed ID: 22704532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
    Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
    Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine Levels in Saliva Are Associated with Salivary Gland Fibrosis and Hyposalivation in Mice after Fractionated Radiotherapy of the Head and Neck.
    Zlygosteva O; Juvkam IS; Aass HCD; Galtung HK; Søland TM; Malinen E; Edin NFJ
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a more patient-specific model of post-radiotherapy saliva secretion for head and neck cancer patients.
    Tuomikoski L; Kapanen M; Collan J; Keyriläinen J; Saarilahti K; Loimu V; Seppälä T; Tenhunen M
    Acta Oncol; 2015; 54(9):1310-6. PubMed ID: 26203929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pilocarpine and biperiden on salivary secretion during and after radiotherapy in head and neck cancer patients.
    Rode M; Smid L; Budihna M; Soba E; Rode M; Gaspersic D
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):373-8. PubMed ID: 10487558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary protein biomarkers for head and neck cancer.
    Amenábar JM; Da Silva BM; Punyadeera C
    Expert Rev Mol Diagn; 2020 Mar; 20(3):305-313. PubMed ID: 31986927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.